| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Blossomhill Therapeutics, Inc. Common Stock (BLSM) have been net buyers, picking up 1,573,900 shares worth roughly $25.2M on balance.
BLSM sits in the Biotechnology industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.61M | - | - | |
| Dir | 2.71M | - | - | |
| Dir | 2.71M | - | - | |
| Dir | 578.5K | - | - | |
| CEO | 124.8K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Gordon Carl L74 | Director | Buy | 625,000 | $16.00 | $10,000,000.00 | +29.9% | |
| Aug 10, 2026 | Orbimed Advisors LLC66 | Director | Buy | 625,000 | $16.00 | $10,000,000.00 | +29.9% | |
| Aug 10, 2026 | Schmid John P.80 | Director | Buy | 6,000 | $16.00 | $96,000.00 | New | |
| Aug 10, 2026 | Keyes Jason A72 | Chief Financial Officer | Buy | 700 | $16.00 | $11,200.00 | New | |
| Aug 10, 2026 | Liptak Vincent Paul | General Counsel | Buy | 4,700 | $15.89 | $74,700.00 | +4.4% | |
| Aug 10, 2026 | Chen Bihua56 | Director, 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +9.5% |